6 August 2016

VERONA PHARMA PLC - Grant of Share Options

PR Newswire

Read more

5 August 2016

Holding(s) in Company

 

Read more

4 August 2016

Holding(s) in Company

 

Read more

3 August 2016

Holding(s) in Company

 

Read more

3 August 2016

Holding(s) in Company

 

Read more

3 August 2016

Holding(s) in Company

 

Read more

2 August 2016

Holding(s) in Company

 

Read more

2 August 2016

Holding(s) in Company - Replacement

The following announcement replaces the notification Ref 9994F issued on 2 August 2016. The amendment is to Section 9 which should read as follows: The voting rights are managed and controlled by Edmond de Rothschild Investment Partners, acting in its capacity of manage…

Read more

1 August 2016

Holding(s) in Company

 

Read more

1 August 2016

Holding(s) in Company



Read more

Innovative Therapies for Respiratory Care

See the 2017 Verona Pharma corporate video 2017

Runtime: 04:05

Go

The Lancet Respiratory Medicine

Peer-reviewed paper in the Lancet's highly-respected medication journal

Basic & Clinical Pharmacology & Toxicology

Peer-reviewed publication on dual PDE3/4 inhibitors as novel treatments for COPD

Close

Verona Pharma plc
3 More London Riverside, London SE1 2RE
T: +44 (0)203 283 4200

Linkedin     Email Us